Brachytherapy
Volume 8, Issue 4 , Pages 373-378 , October 2009

A Contura catheter offers dosimetric advantages over a MammoSite catheter that increase the applicability of accelerated partial breast irradiation

Received 24 March 2009 ,Revised 17 April 2009 ,Accepted 30 April 2009.

References 

  1. Polgar C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma—5-Year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:694–702
  2. Sarin R. Partial-breast treatment for early breast cancer: Emergence of a new paradigm. Nat Clin Pract Oncol. 2005;2:40–47
  3. Bensaleh S, Bezak E, Borg M. Review of MammoSite brachytherapy: Advantages, disadvantages and clinical outcomes. Acta Oncol. 2009;48:487–494
  4. Garza R, Albuquerque K, Sethi A. Lung and cardiac tissue doses in left breast cancer patients treated with single-source breast brachytherapy compared to external beam tangent fields. Brachytherapy. 2006;5:235–238
  5. Stewart AJ, O'Farrell DA, Cormack RA, et al. Dose volume histogram analysis of normal structures associated with accelerated intracavitary partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields. Radiat Oncol. 2008;3:39
  6. Evans SB, Kaufman SA, Price LL, et al. Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: Incidence, pathologic anatomy, and contributing factors. Int J Radiat Oncol Biol Phys. 2006;65:333–339
  7. Vicini F, Beitsch PD, Quiet CA, et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer. 2008;112:758–766
  8. Watkins JM, Harper JL, Dragun AE, et al. Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 2008;7:305–309
  9. Cuttino LW, Keisch M, Jenrette JM, et al. Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-Year results. Int J Radiat Oncol Biol Phys. 2008;71:107–114
  10. Yoshida K, Nose T, Masuda N, et al. Preliminary result of accelerated partial breast irradiation after breast-conserving surgery. Breast Cancer. 2009;16:105–112
  11. Strauss JB, Dickler A. Accelerated partial breast irradiation utilizing balloon brachytherapy techniques. Radiother Oncol. 2009;91:157–165
  12. Wojcicka JB, Lasher DE, Malcom R, et al. Clinical and dosimetric experience with MammoSite-based brachytherapy under the RTOG 0413 protocol. J Appl Clin Med Phys. 2007;8:2654
  13. Jeruss JS, Vicini FA, Beitsch PD, et al. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast. Ann Surg Oncol. 2006;13:967–976
  14. Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis. Int J Radiat Oncol Biol Phys. 2004;60:722–730
  15. Benitez PR, Keisch ME, Vicini F, et al. Five-year results: The initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007;194:456–462
  16. Cuttino LW, Todor D, Rosu M, et al. Skin and chest wall dose with multi-catheter and MammoSite breast brachytherapy: Implications for late toxicity. Brachytherapy. 2009;8:223–226
  17. Dickler A, Seif N, Kirk MC, et al. A dosimetric comparison of MammoSite((R)) and ClearPath high-dose-rate breast brachytherapy devices. Brachytherapy. 2009;8:14–18
  18. Scanderbeg DJ, Yashar C, Rice R, et al. Clinical implementation of a new HDR brachytherapy device for partial breast irradiation. Radiother Oncol. 2009;90:36–42
  19. Ott OJ, Hildebrandt G, Potter R, et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol. 2007;82:281–286
  20. Cassidy LD. Basic concepts of statistical analysis for surgical research. J Surg Res. 2005;128:199–206
  21. Dwyer AJ. Matchmaking and McNemar in the comparison of diagnostic modalities. Radiology. 1991;178:328–330
  22. Gliner JA, Morgan GA, Harmon RJ. Single-factor repeated-measures designs: Analysis and interpretation. J Am Acad Child Adolesc Psychiatry. 2002;41:1014–1016
  23. Wilkinson JB, Boyle T, Song J, et al. Surgeon-performed ultrasound reliably predicts skin spacing and may decrease the rate of MammoSite balloon catheter explantation in patients undergoing brachytherapy for breast cancer. Am J Surg. 2008;196:289–292

 Reprint requests to: Diane Oshiro, Cancer Center of Irvine, 16100 Sand Canyon Avenue, Suite 130, Irvine, CA 92618. Tel.: 949-417-1100; fax: 949-417-1165. E-mail: doshiro@ccoi.org.

 Presented at the 31st Annual San Antonio Breast Cancer Symposium, December 10–14, 2008, San Antonio, TX.

 Financial support: Dr. Wilder has a grant from SenoRx, Inc. (Aliso Viejo, CA) to conduct clinical research involving the Contura catheter.

PII: S1538-4721(09)00265-7

doi: 10.1016/j.brachy.2009.04.002

Brachytherapy
Volume 8, Issue 4 , Pages 373-378 , October 2009

Article Tools

* Image Usage & Resolution